Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

about

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.Conservation of epigenetic regulation by the MLL3/4 tumour suppressor in planarian pluripotent stem cells

P2860

Q54978680-04025919-1324-4274-B935-3F64E5C92AAB Q58759711-14ABAC31-4CCD-48F1-9F8A-46B56DBEDDBE

P2860

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

Item

http://www.wikidata.org/entity/Q41190391

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

@en

type

Item

label

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

@en

prefLabel

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

@en

P1476

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

@en

P2093

C Baldino

http://www.w3.org/2001/XMLSchema#string

G Fetterly

http://www.w3.org/2001/XMLSchema#string

J Caserta

http://www.w3.org/2001/XMLSchema#string

J R Nair

http://www.w3.org/2001/XMLSchema#string

K Belko

http://www.w3.org/2001/XMLSchema#string

K P Lee

http://www.w3.org/2001/XMLSchema#string

T Howell

http://www.w3.org/2001/XMLSchema#string

P2860

Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell

Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

Targeting the Pim kinases in multiple myeloma

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death

A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas

Pim kinase inhibitors: a survey of the patent literature

Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation

The serine/threonine kinase Pim-1

P2888

leu.2016.379

P304

1715-1726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2016.379

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1041871534

http://www.w3.org/2001/XMLSchema#string

P698

28008178

http://www.w3.org/2001/XMLSchema#string

P932

5537056

http://www.w3.org/2001/XMLSchema#string

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

about

P2860

P2860

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932